Coronary Stents Market Research Report - Global Forecast till 2027

Global Coronary Stents Market Research Report: by Products (Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds), By End-Users (Hospitals and clinics, ambulatory surgical center, specialty center, and others) - Forecast Till 2027

ID: MRFR/MED/5473-HCR | February 2021 | Region: Global | 130 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Global Coronary Stents Market is expected to grow significantly over the forecast period. The market held a market value of USD 9,382.63 Million in 2017 and is projected to grow at a CAGR of 7.81% over the forecast period.


Coronary stents are used in the process of angioplasty to make the cross-section of the blood vessel wider. Stents hold the walls of the vessel and thus do not let it sag or shrink, thereby curing the blockages in the vessel. Coronary stents have substantially changed the practice of interventional cardiology by reducing early complications such as abrupt vessel closure and improving late clinical outcome (restenosis). This results in patient and physician satisfaction. Thus, this factor contributes heavily to the growth of this market.


Moreover, the wide acceptance of prosthesis in coronary artery treatment procedures also fuels the market growth. Key companies are also engaged in new product launches related to coronary stents owing to the wide acceptance of the product. For instance, in May 2018, Terumo Europe NV announced the launch of Ultimaster Tansei drug eluting stent in Europe.


The market, by coronary stents, is further segmented into drug eluting stents, bare metal stents, and bioresorbable vascular scaffolds. Drug-eluting stents are metal stents that have been coated with a pharmacologic drug known to suppress restenosis, whereas bare metal stents are stents without a covering or a coating. Bioresorbable vascular scaffolds are intended to provide mechanical support and drug delivery similar to drug eluting stents, followed by complete resorption in some years.


Segmentation:


Global Coronary Stents Market has been segmented into products, and end user.Based on products, the market has been segmented into, Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds. The drug eluting stent segment is expected to account for the largest share in the global coronary stents market in 2017. This large share is majorly attributed to the wider acceptance of the drug eluting stents in the angioplasty procedures, better patient compliance as compared to the bare metal stents. On the other hand, bioresorbable stents are projected to grow at the fastest rate during the forecast period. 


On the basis of end users, the market has been segmented into hospitals & clinics, ambulatory surgical centres, specialty centres, and others. The hospitals & clinics segment is expected to account for the largest share in the global coronary stents market in 2017. At the same time, the increasing establishments of the ambulatory surgical centres in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.Based on the regions, the market for coronary stents is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The coronary stents market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.


European Coronary Stents Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Coronary Stents Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The coronary stents market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical, Elixir Medical Corporation, Medtronic plc, Meril Life Sciences,      MicroPort Scientific Corporation, Stentys SA, and Terumo Corporation are some of the key players in the global coronary stents market.


Regional Market Summary


Global Coronary stents market Share (%), by Region, 2017


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global coronary stents market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and coronary artery disease among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way. According to the data published by the Department of Health, New York in May 2018, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. Besides this, the high medical awareness among American population, high disposable income, presence of the top medical device manufacturers in the region are some of the many factors that drive the growth of the coronary stents market in this region.


Europe is expected to hold the second largest market share in the global coronary stents market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the coronary stents market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the coronary stents market during the forecast period.


Global Coronary Stents Market, by Products:



  • Drug Eluting Stents

  • Bare Metal Stents

  •  Bioresorbable Vascular Scaffolds


Global Coronary Stents Market, by End User:



  •        Hospitals and Clinics

  •        Ambulatory Surgical Centers

  •        Specialty Centers

  •        Others


Global Coronary Stents Market, by Region:



  • Americas

    •  North America

      •  US

      •   Canada



    •  South America



  • Europe

    •  Western Europe

      •   Germany

      •   France

      •   Italy

      •  Spain

      •   UK

      •   Rest of Western Europe



    •  Eastern Europe



  • Asia-Pacific

    •  Japan

    •  China

    •  India

    •  Australia

    •  South Korea

    •  Rest of Asia-Pacific



  •  Middle East & Africa

    •  Middle East

    •  Africa




Global Coronary stents market, by Key Players:



  •        Abbott 

  •        Braun Melsungen AG

  •        Biotronik SE & Co. KG

  •        Boston Scientific Corportaion 

  •        R. Bard, Inc.

  •        Cook Medical

  •        Elixir Medical Corporation

  •        Medtronic plc

  •        Meril Life Sciences

  •        MicroPort Scientific Corporation

  •        Stentys SA

  •        Terumo Corporation

  •       Others


Intended Audience:



  • Coronary Stent Manufacturers and Distributors

  • Cardiology Devices Manufacturers and Distributors

  • Pharmaceutical and Biotechnological Companies

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations


 


 


 


 



Frequently Asked Questions (FAQ) :


Coronary Stents Market valuation in 2017 was USD 9, 382.63 million.

The Coronary Stents Market has the cope to move forward with 7.81% CAGR during the forecast period of 2018 to 2023.

The hospitals & clinics segment has the opportunity to lead the global Coronary Stents Market.

The drug-eluting stent market has a maximum Coronary Stents Market share.

The Americas has a better Coronary Stents Market share.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Coronary Stents Market, by Products

6.1 Introduction

6.2 Drug Eluting Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Bare Metal Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Bioresorbable Vascular Scaffolds

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Coronary Stents Market, By End-User

7.1 Introduction

7.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Specialty Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Coronary Stents Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Abbott

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 B. Braun Melsungen AG

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Biotronik SE & Co. KG

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Boston Scientific Corporation

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 C. R. Bard, Inc.

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Cook Medical

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Elixir Medical Corporation

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Medtronic plc

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Meril Life Sciences

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 MicroPort Scientific Corporation

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Stentys SA

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.10 Terumo Corporation

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Coronary Stents Market Industry

Chapter 12. Appendix


LIST OF TABLES

Table 1 Global Coronary Stents Market Synopsis, 2020-2027

Table 2 Global Coronary Stents Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 4 Global Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 5 Global Coronary Stents Market, by Region, 2020-2027(USD Million)

Table 6 North America: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 7 North America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 8 North America: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 9 US: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 10 US: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 11 US: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 12 Canada: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 13 Canada: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 14 Canada: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 15 South America: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 16 South America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 17 South America: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 18 Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 19 Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 20 Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 21 Western Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 22 Western Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 23 Western Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 24 Eastern Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 25 Eastern Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 26 Eastern Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 27 Asia-Pacific: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Coronary Stents Market, by Region, 2020-2027 (USD Million)

Table 30 Middle East & Africa: Coronary Stents Market, by Product, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Coronary Stents Market, by End-User, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Coronary Stents Market, by Region, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Coronary Stents Market

Figure 3 Segmentation Market Dynamics for Global Coronary Stents Market

Figure 4 Global Coronary Stents Market Share, by Product, 2020 (%)

Figure 5 Global Coronary Stents Market Share, by End-User, 2020 (%)

Figure 6 Global Coronary Stents Market Share, by Region, 2020 (%)

Figure 7 North America: Coronary Stents Market Share, by Country, 2020 (%)

Figure 8 Europe: Coronary Stents Market Share, by Country, 2020 (%)

Figure 9 Asia-Pacific: Coronary Stents Market Share, by Country, 2020 (%)

Figure 10 Middle East & Africa: Coronary Stents Market Share, by Country, 2020 (%)

Figure 11 Global Coronary Stents Market: Company Share Analysis, 2020 (%)

Figure 12 Abbott: Key Financials

Figure 13 Abbott: Segmental Revenue

Figure 14 Abbott: Geographical Revenue

Figure 15 B. Braun Melsungen AG: Key Financials

Figure 16 B. Braun Melsungen AG: Segmental Revenue

Figure 17 B. Braun Melsungen AG: Geographical Revenue

Figure 18 Biotronik SE & Co. KG: Key Financials

Figure 19 Biotronik SE & Co. KG: Segmental Revenue

Figure 20 Biotronik SE & Co. KG: Geographical Revenue

Figure 21 Boston Scientific Corporation: Key Financials

Figure 22 Boston Scientific Corporation: Segmental Revenue

Figure 23 Boston Scientific Corporation: Geographical Revenue

Figure 24 C. R. BARD, INC.: Key Financials

Figure 25 C. R. BARD, INC.: Segmental Revenue

Figure 26 C. R. BARD, INC.: Geographical Revenue

Figure 27 Cook Medical: Key Financials

Figure 28 Cook Medical: Segmental Revenue

Figure 29 Cook Medical: Geographical Revenue

Figure 30 Elixir Medical Corporation: Key Financials

Figure 31 Elixir Medical Corporation: Segmental Revenue

Figure 32 Elixir Medical Corporation: Geographical Revenue

Figure 33 Medtronic plc: Key Financials

Figure 34 Medtronic plc: Segmental Revenue

Figure 35 Medtronic plc: Geographical Revenue

Figure 36 Meril Life Sciences: Key Financials

Figure 37 Meril Life Sciences: Segmental Revenue

Figure 38 Meril Life Sciences: Geographical Revenue

Figure 39 MicroPort Scientific Corporation: Key Financials

Figure 40 MicroPort Scientific Corporation: Segmental Revenue

Figure 41 MicroPort Scientific Corporation: Geographical Revenue

Figure 42 Stentys SA: Key Financials

Figure 43 Stentys SA: Segmental Revenue

Figure 44 Stentys SA: Geographical Revenue

Figure 45 Terumo Corporation: Key Financials

Figure 46 Terumo Corporation: Segmental Revenue

Figure 47 Terumo Corporation: Geographical Revenue